Lantheus Holdings, Inc. (LNTH): Price and Financial Metrics

LNTH POWR Grades

• Quality is the dimension where LNTH ranks best; there it ranks ahead of 90.3% of US stocks.
• The strongest trend for LNTH is in Growth, which has been heading down over the past 177 days.
• LNTH ranks lowest in Momentum; there it ranks in the 9th percentile.

LNTH Stock Summary

• LNTH's current price/earnings ratio is 41.76, which is higher than 85.15% of US stocks with positive earnings.
• With a year-over-year growth in debt of 235.23%, LANTHEUS HOLDINGS INC's debt growth rate surpasses 95.8% of about US stocks.
• As for revenue growth, note that LNTH's revenue has grown 50.43% over the past 12 months; that beats the revenue growth of 90.58% of US companies in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to LANTHEUS HOLDINGS INC are APM, PXLW, BTAI, SDGR, and NVEC.
• LNTH's SEC filings can be seen here. And to visit LANTHEUS HOLDINGS INC's official web site, go to www.lantheus.com.

LNTH Valuation Summary

• In comparison to the median Healthcare stock, LNTH's price/earnings ratio is 74.07% higher, now standing at 42.3.
• Over the past 102 months, LNTH's EV/EBIT ratio has gone up 24.

Below are key valuation metrics over time for LNTH.

LNTH Growth Metrics

The 5 year price growth rate now stands at 1.16%.
• The 4 year net income to common stockholders growth rate now stands at 21.76%.
• Its 4 year revenue growth rate is now at 14.6%.

Over the past 33 months, LNTH's revenue has gone up $454,120,000.

The table below shows LNTH's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	801.457	190.318	107.037
2022-06-30	664.238	101.09	32.39
2022-03-31	541.579	54.362	-37.325
2021-12-31	425.208	53.916	-71.279
2021-09-30	389.798	40.596	-34.476
2021-06-30	376.269	44.831	-27.447

LNTH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• LNTH has a Quality Grade of C, ranking ahead of 29.96% of graded US stocks.
• LNTH's asset turnover comes in at 0.436 -- ranking 105th of 682 Pharmaceutical Products stocks.
• AVDL, OTIC, and SYRS are the stocks whose asset turnover ratios are most correlated with LNTH.

The table below shows LNTH's key quality metrics over time.